|
Market Cap | 873.56B | EPS (ttm) | 44.25 |
P/E | 9.15 | EPS this Y | 6.48% |
Forward P/E | 21.11 | EPS next Y | 4.88% |
PEG | 0.39 | EPS past 5Y | 93.53% |
P/S | 2.40 | EPS next 5Y | 23.30% |
P/B | 1.56 | EPS Q/Q | 109.82% |
Dividend | - | Sales Q/Q | 19.46% |
Insider Own | 39.43% | Inst Own | 39.89% |
Insider Trans | 0.00% | Inst Trans | - |
Short Float | 0.79% | Earnings | Feb 26/b |
Analyst Recom | 2.40 | Target Price | 453.61 |
Avg Volume | 3.49M | 52W Range | 317.41 - 430.00 |
|
|
|
Berkshire Hathaway, Inc. is a holding company, which engages in the provision of property and casualty insurance and reinsurance, utilities and energy, freight rail transportation, finance, manufacturing, and retailing services. It operates through the following segments: Insurance, Burlington Northern Santa Fe, LLC (BNSF), Berkshire Hathaway Energy (BHE), Pilot Travel Centers (PTC), Manufacturing, McLane, and Service and Retailing. The Insurance segment includes the underwriting of GEICO, Berkshire Hathaway Primary Group, and Berkshire Hathaway Reinsurance Group. The BNSF segment involves the operation of railroad systems. The BHE segment focuses on regulated electric and gas utility, power generation and distribution, and real estate brokerage activities. The PTC segment consists of managing travel centers and marketing of wholesale fuel. The Manufacturing segment refers to industrial, consumer and building products, home building, and related financial services. The McLane segment covers the wholesale distribution of groceries and non-food items. The Service and Retailing segment relates to the provision of shared aircraft ownership programs, aviation pilot training, electronic components distribution, retailing businesses, automobile dealerships and trailer, and furniture leasing services. The company was founded by Oliver Chace in 1839 and is headquartered in Omaha, NE. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
BERKSHIRE HATHAWAY INC | 10% Owner | Apr 12 '24 | Buy | 25.58 | 413,227 | 10,570,884 | 69,044,244 | Apr 12 08:03 PM | BERKSHIRE HATHAWAY INC | 10% Owner | Apr 12 '24 | Buy | 25.67 | 317,017 | 8,138,334 | 34,682,219 | Apr 12 07:57 PM | BERKSHIRE HATHAWAY INC | 10% Owner | Apr 11 '24 | Buy | 26.13 | 208,000 | 5,435,726 | 68,631,017 | Apr 12 08:03 PM | BERKSHIRE HATHAWAY INC | 10% Owner | Apr 11 '24 | Buy | 26.19 | 168,650 | 4,417,736 | 34,365,202 | Apr 12 07:57 PM | BERKSHIRE HATHAWAY INC | 10% Owner | Apr 10 '24 | Buy | 25.96 | 513,104 | 13,318,127 | 68,423,017 | Apr 12 08:03 PM |
|
|
|
|
Market Cap | 6.24M | EPS (ttm) | -5.83 |
P/E | - | EPS this Y | 31.37% |
Forward P/E | - | EPS next Y | -217.14% |
PEG | - | EPS past 5Y | -25.24% |
P/S | 8.79 | EPS next 5Y | - |
P/B | 0.70 | EPS Q/Q | -1103.63% |
Dividend | - | Sales Q/Q | -47.93% |
Insider Own | 52.19% | Inst Own | 7.75% |
Insider Trans | 23.51% | Inst Trans | - |
Short Float | 2.86% | Earnings | Feb 27/a |
Analyst Recom | 1.00 | Target Price | 30.05 |
Avg Volume | 2.05M | 52W Range | 1.62 - 44.00 |
|
|
Today 12:13PM
|
12 Cheap Foods With Anti-Aging Properties That Longevity Scientists Swear By
(Insider Monkey) |
Apr-18-24 04:05PM
|
Longeveron Raises a Total of $11.4 Million in Gross Proceeds from Warrant Exercise Offering and Public Offering
(GlobeNewswire) |
Apr-17-24 08:00AM
|
Longeveron Announces Exercise of Warrants for $6.2 Million Gross Proceeds
(GlobeNewswire) -40.79% |
Apr-16-24 01:08PM
|
Hedge Fund and Insider Trading News: Ken Griffin, Per Johansson, David Tepper, Michael Platt, Third Point LLC, Millennium Management, Bridgewater Associates, Paloma Partners, Longeveron Inc (LGVN), MongoDB, Inc. (MDB) and More
(Insider Monkey) +20.48% |
Apr-15-24 08:30AM
|
Longeveron's CLEAR MIND Randomized Phase 2a Clinical Trial Evaluating Lomecel-B in Mild Alzheimer's Disease Accepted for Featured Research Session Oral Presentation at the 2024 Alzheimer's Association International Conference (AAIC)
(GlobeNewswire) +73.37% |
08:24AM
|
Why Is Longeveron (LGVN) Stock Up 48% Today?
(InvestorPlace) |
Apr-11-24 05:17PM
|
Longeveron Announces Closing of $5.2 Million Public Offering
(GlobeNewswire) -10.22% |
Apr-08-24 02:15PM
|
Longeveron Announces Pricing of $5.25 Million Public Offering
(GlobeNewswire) |
08:30AM
|
Longeveron Issues Letter to Shareholders Highlighting Corporate Strategy, Clinical Pipeline and 2024 Key Priorities and Goals
(GlobeNewswire) |
07:56AM
|
Why Is Longeveron (LGVN) Stock Up 82% Today?
(InvestorPlace) |
|
Longeveron, Inc. is a clinical stage biotechnology company, which engages in the development of cellular therapies for specific aging-related and life-threatening conditions. Its lead product, LOMECEL-B, is a cell-based therapy product, which is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young, healthy, adult donors. The company was founded by Joshua M. Hare and Donald M. Soffer on October 9, 2014 and is headquartered in Miami, FL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Hare Joshua | Chief Scientific Officer | Apr 11 '24 | Buy | 2.35 | 42,553 | 100,000 | 633,280 | Apr 12 07:00 PM | Soffer Rock | Director | Apr 11 '24 | Buy | 2.35 | 31,915 | 75,000 | 208,534 | Apr 12 07:00 PM | Hashad Mohamed Wa'el Ahmed | Chief Executive Officer | Apr 11 '24 | Buy | 2.35 | 10,638 | 24,999 | 19,616 | Apr 12 07:00 PM | Hare Joshua | Chief Scientific Officer | Apr 10 '24 | Buy | 2.35 | 106,383 | 250,000 | 590,727 | Apr 12 07:00 PM | Soffer Rock | Director | Apr 10 '24 | Buy | 2.35 | 106,383 | 250,000 | 176,619 | Apr 12 07:00 PM |
|
|
|
|
Market Cap | 146.63M | EPS (ttm) | -0.29 |
P/E | - | EPS this Y | 74.20% |
Forward P/E | - | EPS next Y | 71.40% |
PEG | - | EPS past 5Y | -11.50% |
P/S | 0.51 | EPS next 5Y | - |
P/B | 0.46 | EPS Q/Q | 61.30% |
Dividend | - | Sales Q/Q | 6.80% |
Insider Own | 9.97% | Inst Own | 16.10% |
Insider Trans | 0.13% | Inst Trans | -11.55% |
Short Float | 1.47% | Earnings | Mar 13/b |
Analyst Recom | 2.00 | Target Price | 1.84 |
Avg Volume | 884.72K | 52W Range | 0.55 - 1.57 |
|
|
|
Village Farms International, Inc., together with its subsidiaries, produces, markets, and sells greenhouse-grown tomatoes, bell peppers, and cucumbers in North America. It operates through four segments: Produce, Cannabis-Canada, Cannabis-U.S., and Energy. The company also produces and supplies cannabis products to other licensed providers and provincial governments in Canada and internationally; develops and sells cannabinoid-based health and wellness products, including ingestible, edibles, and topical applications; and produces power. It markets and distributes its products under the Village Farms brand name to retail supermarkets and fresh food distribution companies, as well as products produced under exclusive and non-exclusive arrangements from greenhouse supply partners. The company was formerly known as Village Farms Canada Inc. and changed its name to Village Farms International, Inc. in December 2009. Village Farms International, Inc. was founded in 1989 and is headquartered in Delta, Canada. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
McLernon John R. | Director | Mar 15 '24 | Buy | 0.77 | 14,200 | 10,934 | 15,800 | Apr 12 05:53 PM |
|
|
| |
|
Market Cap | 480.68M | EPS (ttm) | -3.54 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | 8.28% | Sales Q/Q | - |
Insider Own | - | Inst Own | 11.83% |
Insider Trans | - | Inst Trans | - |
Short Float | 0.75% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 132.86K | 52W Range | 9.76 - 14.39 |
|
|
|
Tekla World Healthcare Fund is a closed-ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector. For its fixed income portion, the fund primarily invests in corporate debt securities. Tekla World Healthcare Fund was formed on June 26, 2015 and is domiciled in the United States. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Goetz Kathleen | Director | Apr 09 '24 | Buy | 12.53 | 200 | 2,506 | 1,017 | Apr 12 09:21 AM | Reit Todd | Director | Jan 02 '24 | Buy | 11.94 | 1,000 | 11,936 | 1,000 | Jan 04 02:24 PM |
|
|
|
|
Market Cap | 792.80M | EPS (ttm) | -1.48 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | 5.98% | Sales Q/Q | - |
Insider Own | - | Inst Own | 20.76% |
Insider Trans | - | Inst Trans | - |
Short Float | 0.04% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 171.23K | 52W Range | 15.29 - 20.38 |
|
|
|
Tekla Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating in the healthcare sector. The fund also invests in pooled investment vehicles. For its fixed income portion, the fund invests in corporate debt securities across the credit rating spectrum. It benchmarks the performance of its portfolio against the S&P 1500 Healthcare Index and S&P 500 Index. Tekla Healthcare Opportunities Fund was formed on April 2, 2014 and is domiciled in the United States. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Goetz Kathleen | Director | Apr 09 '24 | Buy | 19.54 | 600 | 11,723 | 1,148 | Apr 12 09:21 AM | Reit Todd | Director | Jan 02 '24 | Buy | 18.44 | 1,000 | 18,436 | 1,000 | Jan 04 02:23 PM | Maher Bill | Director | Dec 28 '23 | Buy | 18.25 | 1,000 | 18,250 | 1,000 | Jan 02 04:35 PM |
|
|
| |
|
Market Cap | 335.51M | EPS (ttm) | 0.79 |
P/E | 16.20 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 95.51 | EPS next 5Y | - |
P/B | 0.79 | EPS Q/Q | - |
Dividend | 7.89% | Sales Q/Q | 34.40% |
Insider Own | - | Inst Own | 33.91% |
Insider Trans | - | Inst Trans | - |
Short Float | 0.08% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 111.02K | 52W Range | 11.34 - 14.37 |
|
|
|
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Goetz Kathleen | Director | Apr 09 '24 | Buy | 13.32 | 400 | 5,327 | 1,085 | Apr 12 09:20 AM | Reit Todd | Director | Jan 02 '24 | Buy | 13.80 | 1,000 | 13,798 | 1,000 | Jan 04 02:23 PM | Maher Bill | Director | Dec 28 '23 | Buy | 13.57 | 1,000 | 13,570 | 1,000 | Jan 02 04:34 PM | OMSTEAD DANIEL R | President | Sep 25 '23 | Buy | 12.39 | 10,096 | 125,116 | 197,518 | Sep 25 05:35 PM | OMSTEAD DANIEL R | President | Sep 20 '23 | Buy | 12.68 | 12,000 | 152,206 | 187,422 | Sep 20 06:40 PM |
|
|
|
|
Market Cap | 765.40M | EPS (ttm) | 1.09 |
P/E | 14.52 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 74.37 | EPS next 5Y | - |
P/B | 0.84 | EPS Q/Q | - |
Dividend | 10.49% | Sales Q/Q | 8.10% |
Insider Own | - | Inst Own | 28.21% |
Insider Trans | - | Inst Trans | - |
Short Float | 0.03% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 160.56K | 52W Range | 14.31 - 17.83 |
|
|
|
Tekla Healthcare Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as current or anticipated market position for services or products, experienced business management, recognized technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotechnology Index, the S&P 500 Index, and the S&P 1500 Healthcare Index. It was previously known as H&Q Healthcare Investors. Tekla Healthcare Investors was formed on October 31, 1986 and is domiciled in the United States. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Goetz Kathleen | Director | Apr 09 '24 | Buy | 16.42 | 525 | 8,622 | 1,080 | Apr 12 09:19 AM | Reit Todd | Director | Jan 02 '24 | Buy | 16.93 | 1,000 | 16,929 | 1,000 | Jan 04 02:22 PM | Maher Bill | Director | Dec 28 '23 | Buy | 16.58 | 1,000 | 16,580 | 1,000 | Jan 02 04:33 PM | Goodson Alan R | Vice President | Dec 21 '23 | Buy | 16.13 | 170 | 2,742 | 170 | Jan 09 12:09 PM | OMSTEAD DANIEL R | President | Sep 25 '23 | Buy | 15.63 | 9,500 | 148,515 | 178,269 | Sep 25 05:34 PM |
|
|
| |
|
Market Cap | 63.74M | EPS (ttm) | -0.00 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | 6.99 | EPS Q/Q | -216.22% |
Dividend | - | Sales Q/Q | - |
Insider Own | 95.17% | Inst Own | 31.17% |
Insider Trans | 2.31% | Inst Trans | - |
Short Float | 4.29% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 45.76K | 52W Range | 10.15 - 15.00 |
|
|
|
Pono Capital Two, Inc. operates as a blank check company, which was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on March 11, 2022 and is headquartered in Honolulu, HI. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
ZUU Co. Ltd. | 10% Owner | Apr 11 '24 | Buy | 12.80 | 4 | 51 | 1,455,060 | Apr 11 09:00 PM | ZUU Co. Ltd. | 10% Owner | Apr 09 '24 | Buy | 12.80 | 1 | 13 | 1,455,056 | Apr 11 09:00 PM | ZUU Co. Ltd. | 10% Owner | Apr 05 '24 | Buy | 12.80 | 2 | 26 | 1,455,055 | Apr 08 09:48 PM | ZUU Co. Ltd. | 10% Owner | Apr 04 '24 | Buy | 12.80 | 2 | 26 | 1,455,053 | Apr 08 09:48 PM | ZUU Co. Ltd. | 10% Owner | Apr 02 '24 | Buy | 12.80 | 4 | 51 | 1,455,051 | Apr 03 08:00 PM |
|
|
|
|
Market Cap | 75.15M | EPS (ttm) | 0.44 |
P/E | 24.30 | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | 19.14 | EPS next 5Y | - |
P/B | 0.89 | EPS Q/Q | - |
Dividend | 3.47% | Sales Q/Q | -36.60% |
Insider Own | 0.33% | Inst Own | 49.93% |
Insider Trans | 12.19% | Inst Trans | - |
Short Float | 0.12% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 19.59K | 52W Range | 10.29 - 11.19 |
|
|
|
DTF Tax-Free Income 2028 Term Fund Inc. is a closed-ended fixed income mutual fund launched by Virtus Investment Partners, Inc. The fund is managed by Duff & Phelps Investment Management Co. It invests primarily in a diversified portfolio of investment grade tax-exempt utility obligations. The fund invests in various sectors, such as water and sewer, electric utilities, prerefunded utilities, pollution control, and nonutilities. It invests in the fixed income markets of the United States. It was formerly known as DTF Tax-Free Income Inc. DTF Tax-Free Income 2028 Term Fund Inc. was formed on November, 1991 and is domiciled in the United States. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Grumhaus David D Jr. | President and CEO | Apr 10 '24 | Buy | 10.70 | 2,500 | 26,750 | 5,014 | Apr 11 07:35 PM | Grumhaus David D Jr. | President and CEO | Apr 09 '24 | Buy | 10.77 | 6 | 65 | 2,514 | Apr 11 07:35 PM |
|
|
|
|
Market Cap | 352.42M | EPS (ttm) | -0.69 |
P/E | - | EPS this Y | - |
Forward P/E | - | EPS next Y | - |
PEG | - | EPS past 5Y | - |
P/S | - | EPS next 5Y | - |
P/B | - | EPS Q/Q | - |
Dividend | 6.83% | Sales Q/Q | - |
Insider Own | 0.10% | Inst Own | 11.16% |
Insider Trans | 9.02% | Inst Trans | - |
Short Float | 0.04% | Earnings | - |
Analyst Recom | - | Target Price | - |
Avg Volume | 144.55K | 52W Range | 7.90 - 12.76 |
|
|
|
Duff & Phelps Utility and Infrastructure Fund Inc is a closed-ended equity mutual fund launched by Virtus Investment Partners, Inc. The fund is managed by Duff & Phelps Investment Management Co. It invests in the public equity markets across the globe. The fund seeks to invest in the companies operating in utility sector. It invests in stocks of companies across diversified market capitalizations. The fund was formerly known as Duff & Phelps Global Utility Income Fund Inc. Duff & Phelps Utility and Infrastructure Fund Inc. was formed on July 29, 2011 and is domiciled in the United States. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Grumhaus David D Jr. | President and CEO | Apr 09 '24 | Buy | 9.42 | 3,000 | 28,260 | 8,000 | Apr 11 07:32 PM | Grumhaus David D Jr. | President and CEO | Jul 31 '23 | Buy | 10.01 | 2,500 | 25,025 | 5,000 | Jul 31 03:49 PM | PETRISKO DANIEL | EVP and Assistant Secretary | Jun 20 '23 | Buy | 9.82 | 450 | 4,417 | 2,471 | Jun 20 01:45 PM | Elvekrog Eric | VP & Chief Investment Officer | Jun 16 '23 | Buy | 10.07 | 3,000 | 30,210 | 16,200 | Jun 16 04:29 PM | Grumhaus David D Jr. | President and CEO | Jun 16 '23 | Buy | 10.08 | 2,500 | 25,200 | 2,500 | Jun 16 07:51 PM |
|
|
|